BB-1709

· Bliss Biopharmaceutical (Hangzhou) Co., Ltd

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BB-1709, covering 2025-09-26 to 2025-09-26. Get the full timeline:

Most recent: Clinical Trial Update: A First-in-human of Multiplle Doses of BB-1709 in Subjects With Locally Advanced/Metastatic Solid Tumors [Phase 1]

See pricing